More about

Psoriatic Arthritis

News
June 22, 2022
3 min read
Save

ACR/AAHKS: Decision to withhold drugs before arthroplasty must weigh flare vs infection

ACR/AAHKS: Decision to withhold drugs before arthroplasty must weigh flare vs infection

Patients with autoimmune rheumatic diseases who are undergoing elective hip or knee arthroplasty should maintain their usual doses of methotrexate, leflunomide, hydroxychloroquine, sulfasalazine and apremilast , according to new guidelines.

News
June 16, 2022
2 min read
Save

Secukinumab minimizes disease activity at 6 months in psoriatic arthritis

Secukinumab minimizes disease activity at 6 months in psoriatic arthritis

Real-world patients with psoriatic arthritis who receive secukinumab for 6 months maintain consistent proportions of minimal disease activity and demonstrate improved patient-reported outcomes, according to data.

News
June 07, 2022
2 min read
Save

‘Very exciting’ data: Bimekizumab superior to placebo in psoriatic arthritis

‘Very exciting’ data: Bimekizumab superior to placebo in psoriatic arthritis

Patients with psoriatic arthritis treated with bimekizumab demonstrated improvements across joint and skin parameters compared with placebo, according to Phase 3 clinical trial data presented at the EULAR 2022 Congress.

News
May 19, 2022
1 min read
Save

Psoriatic arthritis trials should seek deeper remission states, end placebo controls

Psoriatic arthritis trials should seek deeper remission states, end placebo controls

Clinical trials for psoriatic arthritis therapies should place a greater focus on using deeper states of remission as primary and co-primary endpoints, according to speakers at the FDA & American College of Rheumatology Virtual Summit.

News
May 12, 2022
2 min read
Save

Growing psoriatic arthritis armamentarium can target specific disease domains

Growing psoriatic arthritis armamentarium can target specific disease domains

DESTIN, Fla. — An ever-increasing array of treatment options is allowing rheumatologists to target specific disease domains in their patients with psoriatic arthritis, according to a speaker at the Congress of Clinical Rheumatology East.

News
May 10, 2022
1 min read
Save

United Rheumatology, CreakyJoints launch RA resource during Arthritis Awareness Month

United Rheumatology, CreakyJoints launch RA resource during Arthritis Awareness Month

United Rheumatology and CreakyJoints have announced a partnership to launch the Rheumatoid Arthritis Wellness Center, a digital resource that aims to offer support to patients living with RA, according to a press release.

News
May 09, 2022
2 min read
Save

Ixekizumab’s safety profile ‘reassuring’ after 3-year follow-up in psoriatic arthritis

Ixekizumab’s safety profile ‘reassuring’ after 3-year follow-up in psoriatic arthritis

Ixekizumab demonstrates a safety and tolerability profile that is “reassuring” and consistent with previous studies in patients with psoriatic arthritis, according to researchers.

News
May 06, 2022
1 min read
Save

Healio roundup: Key takeaways in psoriasis from Maui Derm 2022

Healio rounded up psoriasis coverage and expert analysis presented and discussed at Maui Derm for Dermatologists in Wailea, Hawaii.

News
May 05, 2022
2 min read
Save

‘Large proportion’ of patients with PsA fail to meet treatment targets

‘Large proportion’ of patients with PsA fail to meet treatment targets

A “large proportion” of patients with psoriatic arthritis fail to reach treatment targets despite medication, with residual musculoskeletal and skin disease frequently observed, according to data published in Rheumatology and Therapy.

News
April 28, 2022
6 min read
Save

JAK inhibitors have significant impact in psoriatic arthritis, but safety concerns remain

JAK inhibitors have significant impact in psoriatic arthritis, but safety concerns remain

Despite some safety concerns, Janus kinase, or JAK, inhibitors, are carving out a place as important treatment options for a number of autoimmune diseases, including psoriatic arthritis.

View more